HH

Hubert Hondermarck

University of Newcastle

Newcastle NSW, Australia
4.60/5 · 5 reviews

Rate Professor Hubert Hondermarck

5 Star3
4 Star2
3 Star0
2 Star0
1 Star0
5.008/20/2025

Inspires a passion for knowledge and growth.

4.005/21/2025

Always respectful and encouraging to all.

5.003/31/2025

Encourages creativity and critical thinking.

4.002/27/2025

Encourages students to think independently.

5.002/4/2025

Great Professor!

About Hubert

Professional Summary: Professor Hubert Hondermarck

Professor Hubert Hondermarck is a distinguished academic and researcher at the University of Newcastle, Australia, with a globally recognized expertise in molecular biology and cancer research. His work has significantly contributed to the understanding of neurotrophins and their role in cancer progression, positioning him as a leading figure in translational medical research.

Academic Background and Degrees

Professor Hondermarck holds advanced degrees in biological sciences, with a focus on molecular and cellular biology. His academic journey includes:

  • PhD in Biological Sciences, specializing in neurotrophin signaling, from the University of Lille, France.
  • Postgraduate training and research in molecular oncology and neuroscience.

Research Specializations and Academic Interests

Professor Hondermarck’s research primarily focuses on the molecular mechanisms of cancer, with an emphasis on the role of neurotrophins and nerve involvement in tumor progression. His key areas of interest include:

  • Cancer biology and neurotrophin signaling pathways.
  • Neural regulation in breast and prostate cancer.
  • Translational research for novel cancer therapies and biomarkers.

Career History and Appointments

Professor Hondermarck has held numerous prestigious positions throughout his career, reflecting his expertise and leadership in the field:

  • Professor of Molecular Oncology, School of Biomedical Sciences and Pharmacy, University of Newcastle, Australia (current).
  • Director of the Hunter Medical Research Institute’s Cancer Research Program.
  • Previous academic and research roles at the University of Lille, France, and other international institutions.

Major Awards, Fellowships, and Honors

Professor Hondermarck has been recognized for his groundbreaking contributions to cancer research through various awards and honors, including:

  • Recipient of multiple research grants from the Australian Research Council (ARC) and National Health and Medical Research Council (NHMRC).
  • Recognition for innovative contributions to cancer biology by international scientific communities.

Key Publications

Professor Hondermarck has authored and co-authored numerous high-impact publications in peer-reviewed journals. Some of his notable works include:

  • Hondermarck, H., et al. (2018). 'Neurotrophins and their receptors in breast cancer.' Cancer Research.
  • Hondermarck, H., et al. (2012). 'Nerve involvement in cancer: A previously underestimated factor.' Nature Reviews Cancer.
  • Hondermarck, H., et al. (2020). 'Neural regulation of prostate cancer progression.' Journal of Clinical Oncology.

His publications are widely cited, reflecting his influence in the fields of oncology and molecular biology.

Influence and Impact on Academic Field

Professor Hondermarck’s pioneering research on the role of neurotrophins in cancer has opened new avenues for understanding tumor microenvironments and developing targeted therapies. His work has influenced both basic science and clinical research, contributing to potential diagnostic and therapeutic strategies for cancer patients. He is frequently invited as a keynote speaker at international conferences, further amplifying his impact on the global scientific community.

Public Lectures, Committees, and Editorial Contributions

Professor Hondermarck is actively involved in the broader academic and scientific community through various roles:

  • Regular speaker at international symposia on cancer biology and neurotrophin research.
  • Member of editorial boards for prominent journals in oncology and molecular biology.
  • Serves on advisory committees for cancer research funding bodies in Australia and internationally.